Loading...
Patent Expirations And Generics Will Erode Revenues Yet Spark Hope
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
39.7%7D
25.4%1Y
39.7%7D
25.4%You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.
You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.